Literature DB >> 17249851

Letter from the Commissioner's Office at the US FDA.

John A Vernon.   

Abstract

Mesh:

Year:  2007        PMID: 17249851     DOI: 10.2165/00019053-200725020-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Economic and developmental considerations for pharmacogenomic technology.

Authors:  John A Vernon; Scott J Johnson; W Keener Hughen; Antonio Trujillo
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Do pharmacogenomic tests provide value to policy makers?

Authors:  Ya-Chen Tina Shih; Lajos Pusztai
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.

Authors:  Louis P Garrison; M J Finley Austin
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.